News

The grant, which targets therapeutic discovery projects that show a reasonable potential to result in new therapies to treat areas of unmet medical need or to treat chronic

Perrigo has posted a net income of $74.38m for the first quarter 2010, or $0.80 per diluted share, compared to $51.86m, or $0.56 per diluted share, for the

This pharmaceutical optimisation followed the demonstration of safety and the presumption of efficacy of oral doses as high as 4mg of inecalcitol per day in a Phase IIa

Data from Phase I/II study showed that treatment with Everolimus was associated with a significant reduction in primary SEGA volume at six months relative to baseline on independent

Adventrx retains exclusive worldwide rights to Exelbine, other than in China, Hong Kong, Macau and Taiwan. Adventrx said that the FDA conditionally accepted Exelbine as the proposed proprietary

Biogen Idec said that the step is consistent with its strategic decision to narrow its research and development (R&D) focus and terminate its efforts in cardiovascular medicine that

The agreement combines Sony DADC’s Blu-ray Disc manufacturing technology and manufacturing capacity with Caliper’s microfluidics expertise and patent portfolio to develop enabling solutions for life science researchers and

Mannatech has posted a net loss of $1.29m for the third quarter 2010, or $0.05 loss per diluted share, compared to $9.21m, or $0.35 loss per diluted share,

The FilmArray RP is a user-friendly multiplex PCR assay, which is designed for the detection and differentiation of a panel of respiratory viruses and bacteria. Idaho Technology CEO